UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

VEGF-Induced Vascular Permeability Is Mediated by FAK

Developmental cell, 2012-01, Vol.22 (1), p.146-157

2012

Volltextzugriff (PDF)

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

Nature medicine, 2010-08, Vol.16 (8), p.909-914

2010

Volltextzugriff (PDF)

P045 Effect of Etrasimod on Circulating Lymphocyte Subsets: Data From a Randomized Phase 1 Study in Healthy Japanese and Caucasian Men

The American journal of gastroenterology, 2020-12, Vol.115 (Suppl 1), p.S12-S12

2020

Volltextzugriff (PDF)

A role for VEGF as a negative regulator of pericyte function and vessel maturation

Nature, 2008-12, Vol.456 (7223), p.809-813

2008

Volltextzugriff (PDF)

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor

Blood, 2008-03, Vol.111 (5), p.2674-2680

2008

Volltextzugriff (PDF)

Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence

The Journal of cell biology, 2008-01, Vol.180 (1), p.101-112

2008

Volltextzugriff (PDF)

Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis

International Journal of Obesity, 2019-10, Vol.43 (10), p.2085-2094

2019

Volltextzugriff (PDF)

Targeted nanogels: a versatile platform for drug delivery to tumors

Molecular cancer therapeutics, 2011-06, Vol.10 (6), p.972-982

2011

Volltextzugriff (PDF)

Identification of a Receptor Necessary for Nogo-B Stimulated Chemotaxis and Morphogenesis of Endothelial Cells

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (29), p.10997-11002

2006

Volltextzugriff (PDF)

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

BMC gastroenterology, 2018-01, Vol.18 (1), p.3-17, Article 3

2018

Volltextzugriff (PDF)

Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease

The Journal of pharmacology and experimental therapeutics, 2009-03, Vol.328 (3), p.758

2009

Volltextzugriff (PDF)

Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on raf-1-mediated inhibition of the proapoptotic kinase, ASK1

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2766-2772

2007

Volltextzugriff (PDF)

hESC Differentiation toward an Autonomic Neuronal Cell Fate Depends on Distinct Cues from the Co-Patterning Vasculature

Stem cell reports, 2015-06, Vol.4 (6), p.1075-1088

2015

Volltextzugriff (PDF)

In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation

Nature medicine, 2000-12, Vol.6 (12), p.1362-1367

2000

Volltextzugriff (PDF)

Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF

Proceedings of the National Academy of Sciences - PNAS, 2010-03, Vol.107 (9), p.4299-4304

2010

Volltextzugriff (PDF)

A new role for Nogo as a regulator of vascular remodeling

Nature medicine, 2004-04, Vol.10 (4), p.382-388

2004

Volltextzugriff (PDF)

Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function

The Journal of biological chemistry, 2007-10, Vol.282 (42), p.30745-30753

2007

Volltextzugriff (PDF)

Targeting of Endothelial Nitric-oxide Synthase to the Cytoplasmic Face of the Golgi Complex or Plasma Membrane Regulates Akt- Versus Calcium-dependent Mechanisms for Nitric Oxide Release

The Journal of biological chemistry, 2004-07, Vol.279 (29), p.30349-30357

2004

Volltextzugriff (PDF)

Robo4 counteracts VEGF signaling

Nature medicine, 2008-04, Vol.14 (4), p.372-373

2008

Volltextzugriff (PDF)

Suppressing NFAT Increases VEGF Signaling in Hemangiomas

Cancer cell, 2008-12, Vol.14 (6), p.429-430

2008

Volltextzugriff (PDF)

Su100 EFFECT OF ETRASIMOD ON CIRCULATING LYMPHOCYTE SUBSETS: DATA FROM A RANDOMIZED PHASE 1 STUDY IN HEALTHY JAPANESE AND CAUCASIAN MEN

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-617-S-617

2021

Volltextzugriff (PDF)

A role for VEGF as a negative regulator of pericyte function and vessel maturation

Nature (London), 2009-02, Vol.457 (7233), p.1168-1168

2009

Volltextzugriff (PDF)

Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.2891-2891

2021

Volltextzugriff (PDF)

Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S287-S288

2022

Volltextzugriff (PDF)

371 - Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S287-S288

2022

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

VEGF-Induced Vascular Permeability Is Mediated by FAK

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

P045 Effect of Etrasimod on Circulating Lymphocyte Subsets: Data From a Randomized Phase 1 Study in Healthy Japanese and Caucasian Men

A role for VEGF as a negative regulator of pericyte function and vessel maturation

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor

Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence

Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis

Targeted nanogels: a versatile platform for drug delivery to tumors

Identification of a Receptor Necessary for Nogo-B Stimulated Chemotaxis and Morphogenesis of Endothelial Cells

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease

Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on raf-1-mediated inhibition of the proapoptotic kinase, ASK1

hESC Differentiation toward an Autonomic Neuronal Cell Fate Depends on Distinct Cues from the Co-Patterning Vasculature

In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation

Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF

A new role for Nogo as a regulator of vascular remodeling

Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function

Targeting of Endothelial Nitric-oxide Synthase to the Cytoplasmic Face of the Golgi Complex or Plasma Membrane Regulates Akt- Versus Calcium-dependent Mechanisms for Nitric Oxide Release

Robo4 counteracts VEGF signaling

Suppressing NFAT Increases VEGF Signaling in Hemangiomas

Su100 EFFECT OF ETRASIMOD ON CIRCULATING LYMPHOCYTE SUBSETS: DATA FROM A RANDOMIZED PHASE 1 STUDY IN HEALTHY JAPANESE AND CAUCASIAN MEN

A role for VEGF as a negative regulator of pericyte function and vessel maturation

Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease

Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease

371 - Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease

Suchergebnisse filtern